Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
0.215
0.00 (0.00%)
Apr 9, 2024, 11:42 AM EDT - Market open
Integrated BioPharma Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.67 | 56.25 | 63.56 | 52.77 | 49.98 | 43.71 | 46.95 | 42.21 | 37.49 | 33.68 | Upgrade
|
| Revenue Growth (YoY) | -9.91% | -11.51% | 20.45% | 5.59% | 14.34% | -6.91% | 11.23% | 12.61% | 11.30% | 0.18% | Upgrade
|
| Cost of Revenue | 46.61 | 49.69 | 54.08 | 46.04 | 43.76 | 38.72 | 40.29 | 36.71 | 33.1 | 28.8 | Upgrade
|
| Gross Profit | 4.06 | 6.55 | 9.48 | 6.73 | 6.22 | 4.99 | 6.67 | 5.5 | 4.39 | 4.88 | Upgrade
|
| Selling, General & Admin | 3.94 | 3.81 | 3.7 | 3.47 | 3.52 | 3.29 | 3.48 | 3.39 | 3.46 | 3.53 | Upgrade
|
| Other Operating Expenses | 0.04 | -0.09 | 0.06 | -0.27 | -0.02 | 0.1 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 3.94 | 3.81 | 3.7 | 3.47 | 3.52 | 3.29 | 3.48 | 3.39 | 3.46 | 3.53 | Upgrade
|
| Operating Income | 0.12 | 1.97 | 5.78 | 2.38 | 2.7 | 1.69 | 3.19 | 2.11 | 0.93 | 1.35 | Upgrade
|
| Interest Income | 0.01 | 0.13 | 0.26 | 0.4 | 0.63 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.04 | 0.11 | 0.26 | 0.4 | 0.63 | 0.93 | 0.78 | 0.95 | 0.98 | 0.96 | Upgrade
|
| Other Expense / Income | -0.01 | -0.61 | -1.46 | -0.7 | 0.66 | -0.24 | 0.55 | -0.03 | -0.92 | 0.17 | Upgrade
|
| Pretax Income | 0.1 | 2.6 | 7.25 | 3.09 | 2.04 | 1.01 | 1.86 | 1.19 | 0.87 | 0.22 | Upgrade
|
| Income Tax | 0.13 | -1.24 | -0.77 | -1.02 | 0.35 | 0.33 | -0.49 | 0.23 | 0.13 | 0.09 | Upgrade
|
| Net Income | -0.03 | 3.84 | 8.01 | 4.11 | 1.69 | 0.68 | 2.35 | 0.96 | 0.74 | 0.13 | Upgrade
|
| Net Income Growth | - | -52.10% | 95.06% | 143.36% | 148.60% | -71.06% | 144.89% | 30.34% | 461.07% | 40.86% | Upgrade
|
| Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 29 | 30 | 21 | 21 | 21 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 32 | 32 | 31 | 30 | 30 | 30 | 21 | 29 | 21 | Upgrade
|
| Shares Change | -7.34% | 0.65% | 3.07% | 5.31% | -2.41% | 0.48% | 42.39% | -27.89% | 38.65% | -0.23% | Upgrade
|
| EPS (Basic) | -0.00 | 0.13 | 0.27 | 0.14 | 0.06 | 0.02 | 0.11 | 0.05 | 0.03 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.12 | 0.25 | 0.13 | 0.06 | 0.02 | 0.10 | 0.05 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | - | -52.00% | 92.31% | 128.07% | 154.46% | -77.60% | 100.00% | 150.00% | 100.00% | 127.27% | Upgrade
|
| Free Cash Flow | 1.12 | 3.61 | 2.76 | 1.13 | -0.09 | 0.92 | 0.07 | -0.7 | -0.35 | 1.7 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.11 | 0.09 | 0.04 | -0.00 | 0.03 | 0.00 | -0.03 | -0.01 | 0.08 | Upgrade
|
| Gross Margin | 8.01% | 11.65% | 14.92% | 12.75% | 12.45% | 11.41% | 14.20% | 13.04% | 11.72% | 14.50% | Upgrade
|
| Operating Margin | 0.24% | 3.50% | 9.10% | 4.52% | 5.41% | 3.88% | 6.79% | 5.01% | 2.49% | 4.01% | Upgrade
|
| Profit Margin | -0.07% | 6.82% | 12.61% | 7.78% | 3.38% | 1.55% | 5.00% | 2.27% | 1.96% | 0.39% | Upgrade
|
| Free Cash Flow Margin | 2.20% | 6.41% | 4.33% | 2.13% | -0.17% | 2.11% | 0.15% | -1.67% | -0.93% | 5.03% | Upgrade
|
| Effective Tax Rate | 134.00% | -47.79% | -10.57% | -33.03% | 17.34% | 32.44% | -26.40% | 19.43% | 15.42% | 40.45% | Upgrade
|
| EBITDA | 1.3 | 2.8 | 6.67 | 3.16 | 3.46 | 2.14 | 3.45 | 2.47 | 1.34 | 1.74 | Upgrade
|
| EBITDA Margin | 2.57% | 4.98% | 10.49% | 5.98% | 6.92% | 4.90% | 7.34% | 5.84% | 3.57% | 5.17% | Upgrade
|
| Depreciation & Amortization | 1.15 | 0.83 | 0.83 | 0.77 | 0.77 | 0.35 | 0.39 | 0.35 | 0.41 | 0.39 | Upgrade
|
| EBIT | 0.15 | 1.97 | 5.84 | 2.38 | 2.69 | 1.8 | 3.05 | 2.11 | 0.93 | 1.35 | Upgrade
|
| EBIT Margin | 0.29% | 3.50% | 9.19% | 4.52% | 5.37% | 4.11% | 6.50% | 5.01% | 2.49% | 4.01% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.